TNF and interstitial lung disease: A possible link between the use of anti-TNF drugs and the presence or progression of ILD was hypothesized, and recent evidence has suggested the apparent non-efficacy of TNFα inhibitors in controlling/reducing ILD progression with respect to other treatments (i.e., abatacept, rituximab) [57,58].